Seoul National University Hospital CILON-T Late Breaking Trial : Randomized prospective trial of dual vs. triple antiplatelet therapy after DES implantation.
CardioVascular Research Foundation Asan Medical Center Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety.
Slide 1 PERSEUS Primary Endpoint Dean Kereiakes ACC/i2 Late Breaking Trial Monday, March 15, 2010, 11:06 am TAXUS PERSEUS A Novel Platinum Chromium, Thin-Strut.
Should we dilate the non- infarct related arteries in patients with multi-vessel disease? Carma Karam, MD Cardiologist AIHP, ACCA, FACC Clinique Médicale.
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
Samir rafla real life outcome of atrial fibrillation ablation-cardio alex 2014
ARMOUR
Revison knee for FRCS Orth Course Newcastle UK
jurnal ebm 2
prasugrel
Hemicortical Resection and Inlay Allograft Reconstruction for Primary Bone Tumors by M.P.A. Bus, J.A.M. Bramer, G.R. Schaap, H.W.B. Schreuder, P.C. Jutte,
